October 9, 2017 — The U.S. Food and Drug Administration (FDA) is evaluating recent information regarding Type IIIa and IIIb endoleaks with the use of endovascular graft systems indicated for a procedure known as endovascular aneurysm repair (EVAR). EVAR treats abdominal aortic aneurysms (AAA) and aorto-iliac-aneurysms.

October 5, 2017 — To provide lifesaving surgical care for sick children in one of the most underserved countries, 13 volunteers including 10 medical personnel from Cincinnati Children’s Hospital Medical Center recently completed their second annual mission to Tanzania. Toshiba Medical, a Canon Group company, donated its Viamo portable ultrasound system during the mission at Bugando Medical Centre in Mwanza, Tanzania, serving about 13 million people in the region.

BTG plc announced it has acquired Roxwood Medical, provider of advanced cardiovascular specialty catheters used in the treatment of patients with severe coronary and peripheral artery disease.


Consolidation of data in one location to improve efficiency and enable data analytics, as well as smooth integration with enterprise electronic medical record (EMR) systems are the two main priorities for most hospitals today looking for a new cardiovascular information system (CVIS). CVIS vendors worked over the past several years to create truly vendor-neutral systems that enable a single point of access to patient information from different sources.


TVA Medical Inc. announced that its everlinQ 4 endoAVF System has received CE Mark in the European Union. The technology uses a 4 French catheter system with enhanced visual indicators to create hemodialysis access using an endovascular technique without open surgery.

October 4, 2017 — MyoKardia Inc. recently provided a clinical update on its MYK-491 program for dilated cardiomyopathy.

Earlier this year, MyoKardia initiated a Phase 1 single ascending dose trial of MYK-491 in healthy volunteers. The objectives of this randomized, placebo-controlled trial are to assess safety, tolerability, preliminary pharmacokinetics and pharmacodynamics of MYK-491.

October 4, 2017 — Medtronic received U.S. Food and Drug Administration (FDA) approval for its HeartWare HVAD System as a destination therapy for patients with advanced heart failure who are not candidates for heart transplants. The HVAD System, a left ventricular assist device (LVAD), helps the heart pump and increases the amount of blood that flows through the body.


Despite expectations to the contrary, a new survey from cardiovascular healthcare consulting firm MedAxiom finds that overall, cardiology compensation continues to increase. The company’s fifth annual Cardiovascular Provider Compensation and Production Survey also revealed that one in five cardiologists is over the age of 61, and that overall compensation for private cardiologists is increasing faster than that of their integrated counterparts; the differential in compensation is at its lowest point in five years.


October 3, 2017 – Medical Metrics, an experienced core laboratory for multi-center clinical trials, has implemented the Digisonics Cardiovascular Information System (CVIS) for cardiology research. Digisonics provides cardiologists with remote functionality via Virtual Desktop Infrastructure (VDI), Digisonics’ latest platform validated for secured access to cardiology images.

October 2, 2017 — Cardiovascular healthcare membership organization and performance community MedAxiom announced its corporate partnership with pMD to help advance value-based cardiovascular healthcare. pMD is a healthcare technology provider that improves the physician experience and patient care through a platform focused on mobile charge capture and HIPAA-compliant information sharing.

Subscribe Now